PAM
RCKT icon

Panagora Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Panagora Asset Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-348,803
Closed -$1.22M – 1254
2025
Q4 		$1.22M Buy
+348,803
New +$1.19M ﹤0.01% 660
2018
Q2 		– Sell
-3,151
Closed -$59K – 2408
2018
Q1 		$59K Buy
+3,151
New +$51.4K ﹤0.01% 1985
2017
Q3 		– Sell
-38,553
Closed -$293K – 2463
2017
Q2 		$293K Sell
38,553
-1,060
-3% -$7.9K ﹤0.01% 1512
2017
Q1 		$317K Buy
+39,613
New +$266K ﹤0.01% 1496
2016
Q4 		– Sell
-3,011
Closed -$114K – 2410
2016
Q3 		$114K Buy
+3,011
New +$94.7K ﹤0.01% 1931
2016
Q1 		– Sell
-2,345
Closed -$106K – 2331
2015
Q4 		$106K Buy
+2,345
New +$102K ﹤0.01% 1782

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Panagora Asset Management's RCKT Position: Q1 2026 in Review

Panagora Asset Management sold out of Rocket Pharmaceuticals (RCKT) in Q1 2026, closing a stake of 348,803 shares — an estimated $1.22M sold.

Panagora Asset Management first reported a position in RCKT in Q4 2015 and held it in 6 quarters. The position peaked at $1.22M in Q4 2025. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Panagora Asset Management reported no remaining Rocket Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Panagora Asset Management sold 348,803 Rocket Pharmaceuticals shares in Q1 2026, an estimated $1.22M.
  • Panagora Asset Management first reported a position in Rocket Pharmaceuticals in Q4 2015 and held it in 6 quarters.
  • Panagora Asset Management's Rocket Pharmaceuticals position peaked at $1.22M in Q4 2025.
  • 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.